Fred Hutch Cancer Center

Seattle, Washington 98195

12 studies enrolling now · 14 studies all time

What they study most

Advanced Adenocarcinoma, Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Breast Neoplasms, CRC, Cancer, Carcinoma, Ductal, Breast, Chronic Lymphocytic Leukemia (CLL), Chronic Myelomonocytic Leukemia (CMML), Colon Cancer

Studies at this site

• Selinexor and Backbone Treatments of Multiple Myeloma Patients — Recruiting now
• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study) — Recruiting now
• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — Recruiting now
• A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies — Recruiting now
• Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer — Recruiting now
• Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. — Recruiting now
• A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression — Recruiting now
• ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study) — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors — Running, not enrolling
• A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML — Stopped early
• The PharmFIT Study — Starting soon
• Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors — Starting soon
• EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma — Starting soon